Genesis Research Group to launch Keystone evidence planning platform at ISPOR Europe 2026

Genesis Research Group will debut Keystone, a modular integrated evidence generation planning platform, at ISPOR Europe 2026 in London. The launch is part of a broader showcase that includes an HEOR Theater session, Booth 211 demos and 11 scientific posters tied to the conference.

Why it matters: - Keystone is designed to help life sciences teams replace fragmented evidence planning across slide decks, spreadsheets and separate workstreams with a single governed environment. - The platform is built to connect value strategy, evidence gaps, prioritization, tactical planning and execution in one digital workspace. - Genesis says the approach supports a living evidence strategy across the product lifecycle and helps teams maintain one product strategy, one evidence agenda and one set of shared priorities.

What happened: - Genesis Research Group will launch Keystone, its modular platform for Integrated Evidence Generation Planning, at ISPOR Europe 2026. - The launch is tied to the conference in London, where Genesis will also present at its HEOR Theater session on Monday, November 9, from 12:45-1:15 PM. - Priti Jhingran, PhD, Vice President and Head of HEOR Strategy & Partnerships, will present the session, titled "How Early Is Early Enough? Rethinking Evidence Planning for Today's Global Access Challenges." - Attendees can visit Booth 211 to see Keystone, try EVID AI™, learn about RPR™ and speak with Genesis experts on MFN pricing, HEOR, real-world evidence and market access and pricing strategy.

The details: - Keystone was developed from Genesis's experience building value and evidence strategies and integrated evidence generation plans for global clients. - The platform aims to move evidence planning away from periodic reviews toward a coordinated, continuously managed process. - Genesis says Keystone helps teams align around a shared evidence agenda, prioritize the evidence that matters most and turn evidence needs into actionable plans. - The company will also use ISPOR Europe to highlight EVID AI™, its full-spectrum evidence synthesis platform, and RPR™, its global payer and stakeholder engagement platform. - Genesis Research Group, an official ISPOR corporate partner, contributed 11 poster presentations to this year’s scientific program across artificial intelligence, health economics, market access, evidence synthesis and patient-centered outcomes research. - One of those posters ranked among the top 5% of research submissions to the event. - Genesis will host a complimentary reception at Booth 211 from 5:00-6:00 PM on Monday, November 9. - More information is available at Genesisrg.com.

Between the lines: - The launch signals that evidence planning software is becoming a more strategic, cross-functional layer of commercialization and access work. - Genesis is positioning Keystone as a response to earlier decision-making, broader coordination and more demanding global evidence requirements. - The conference programming suggests Genesis is using ISPOR Europe to showcase both software and subject-matter expertise in one place.

What's next: - Visitors to ISPOR Europe can meet Genesis at Booth 211, view Keystone and attend the reception on November 9. - The HEOR Theater presentation will give Genesis a forum to argue for continuous evidence planning as market access expectations evolve. - Genesis is likely to use the conference to drive follow-up meetings around Keystone and its broader evidence, HEOR and pricing services.